LOGIN  |  REGISTER
Recursion
Cue Biopharma

Enhabit Home Health & Hospice Acquires Southwest Florida Home Care, Inc.’s Fort Meyers, Fla. Location

December 01, 2022 | Last Trade: US$8.56 0.20 2.39

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice provider, today announced the acquisition of Southwest Florida Home Care, Inc.’s home health agency located in Fort Meyers, Fla.

“We are excited to welcome the Southwest Florida Home Care employees to our Enhabit team,” Enhabit President and CEO Barb Jacobsmeyer says. “We look forward to continuing to support our new team members as we serve more patients in need of high-quality home health services.”

This acquisition increases Enhabit’s existing footprint in Florida, which now totals 22 home health locations. The Fort Meyers location will expand Enhabit’s ability to serve the communities of southwest Florida.

Enhabit is the fourth largest provider of Medicare-certified home health services and the 12th largest provider of Medicare-certified hospice services nationally.

To learn more about Enhabit and its care offerings, visit ehab.com, and to apply to join the growing Enhabit team, visit careers.ehab.com.

About Enhabit Home Health & Hospice

Enhabit Home Health & Hospice (Enhabit, Inc.) is a leading national home health and hospice provider working to expand what’s possible for patient care in the home. Enhabit’s team of clinicians supports patients and their families where they are most comfortable, with a nationwide footprint spanning 250 home health locations and 100 hospice locations across 34 states. Enhabit leverages advanced technology and compassionate teams to deliver extraordinary patient care. For more information, visit ehab.com.

 

Assertio

Stock Quote

Featured Stock

Astria Therapeutics

Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...

CLICK TO LEARN MORE

Featured Stock

ClearPoint Neuro

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page